Local News: Sunrise Manor, NV 

 | 

Sign Up

 | 

Sign In

Advertisment

GlaxoSmithKline

GlaxoSmithKline Wire

Comprehensive News Feed for GlaxoSmithKline.

Results 1 - 20 of 3,648 in GlaxoSmithKline

  1. Clinical WireRead the original story

    Jan 12, 2009 | ADVANCE for Nurses

    Posted Dec. 10, 2009 The 'Cervarix' human papilloma virus vaccine from GlaxoSmithKline offers sustained protection beyond 6 years from infection against the types of HPV most commonly associated with cervical cancer, namely HPV-16 and HPV-18. ... Posted Dec.

    Comment?

    Related Topix: Medicine, Hispanic Broadcasting, Television, Lake Forest, IL, Nursing, Opinion

  2. SA investors can now trade in Microsoft, Google futuresRead the original story

    32 min ago | Business Report

    ... such as Berkshire Hathaway, Bank of America, Nokia, LVMH Moet Hennessy Louis Vuitton, BP, Vodafone and GlaxoSmithKline. "While retail investors and corporate entities do not have any exchange control restrictions, institutional investors do have to ...

    Comment?

    Related Topix: Microsoft, Google, Startups, Microsoft, Software, Google, Retail, Tuesday Morning

  3. Research and Markets: Oral Hygiene Products: A Global Market...Read the original story

    1 hr ago | BusinessWire

    ... America Companies Profiled Church & Dwight (US) Colgate-Palmolive (US) Dentaid (Spain) Dr. Fresh Inc. (US) GlaxoSmithKline (UK) Henkel KgaA (Germany) Johnson & Johnson (US) Jordan AS (Norway) Kao Corp (Japan) Lion Corp (Japan) Procter & Gamble (US) ...

    Comment?

  4. GSK has paid $1 billion in Paxil suits, Bloomberg reportsRead the original story w/Photo

    19 hrs ago | Blogs.newsobserver.com

    GlaxoSmithKline has paid nearly $1 billion to resolve lawsuits over Paxil since it began selling the antidepressant in 1993, Bloomberg News reported, citing court records and people familiar with the cases.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Research Triangle Park, NC

  5. GSK's $1B Paxil Problem Highlights Murky Disclosures From Euro Drug CompaniesRead the original story w/Photo

    4 hrs ago | BNET

    British drug company GlaxoSmithKline has paid $1 billion to settle lawsuits related to Paxil .

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Eli Lilly, AstraZeneca Group

  6. GSK to focus on supply deals with generic majorsRead the original story

    4 hrs ago | Business Standard

    European drug major GlaxoSmithKline has said its business strategies in emerging markets, including India, will be driven by its supply partnerships with generic companies such as Dr Reddy's here and Aspen of South Africa.

    Comment?

    Related Topix: Biotech

  7. IOM Issues Review Of National Vaccine Strategy, Recommends Improving Global Vaccine AccessRead the original story

    4 hrs ago | MediLexicon

    ... to develop a research agenda, it says" (Reinberg, 12/11). The Wall Street Journal reports on a deal between GlaxoSmithKline and Intercell "to develop needle-free vaccines delivered through a patch, a technology that could broaden vaccine use by ...

    Comment?

  8. Report: GSK paid nearly $1 billion for Paxil suitsRead the original story

    9 hrs ago | Drug Store News

    NEW YORK British drug maker GlaxoSmithKline has paid nearly $1 billion to settle lawsuits filed by patients taking one of its antidepressant drugs, according to published reports.

    Comment?

    Related Topix: Medicine, Paxil, Paxil CR, Paroxetine (generic), Medication, Biotech

  9. Antidepressants May Change Personality, Leading to Reduced Depression, Says Penn CollaborationRead the original story

    10 hrs ago | Media Newswire

    ... of Archives of General Psychiatry. Research was supported by the National Institute of Mental Health and GlaxoSmithKline. Researchers randomly assigned 240 participants with major depressive disorder, or MMD, to take a placebo for eight weeks, ...

    Comment?

    Related Topix: Depression, Health, Pennsylvania, Vanderbilt University, University of Pennsylvania, Pennsylvania Government, Northwestern University

  10. GSK paid $1bn to dismiss legal claimsRead the original story

    Yesterday | This Is Money

    GlaxoSmithKline has paid almost $1bn to settle American legal claims linked to its controversial antidepressant Seroxat, it emerged yesterday.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry

  11. GSK publishes speaking, consulting fees paid to US healthcare professionalsRead the original story

    13 hrs ago | WebWire

    GlaxoSmithKline today published a list of fees paid between April 1 and June 30 to U.S. healthcare professionals for speaking and consulting services.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry

  12. Bloomberg: GSK has paid $1B in Paxil lawsuitsRead the original story

    20 hrs ago | Triangle Business Journal

    GlaxoSmithKline , the London-based pharmaceutical giant with U.S. headquarters in Research Triangle Park, has paid close to $1 billion since 1993 to resolve lawsuits surrounding its antidrepessant Paxil, according to a report from Bloomberg News.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Research Triangle Park, NC

  13. Drug Combo Extends Life With Breast CancerRead the original story

    Friday Dec 11 | MedicineNet

    ... women with early-stage breast cancer, for whom they expect it to work even better. The study was funded by GlaxoSmithKline, which makes Tykerb. Blackwell consults for GlaxoSmithKline and for Genentech, maker of Herceptin. Also at the meeting, two ...

    Comment?

    Related Topix: Medicine, Health, Breast Cancer

  14. Paxil settlements, costs total nearly $1 billion for GSK - ReportRead the original story

    17 hrs ago | Local Tech Wire

    Get the latest news alerts: Follow LTW at Twitter. Local Tech Wire RESEARCH TRIANGLE PARK, N.C. Settlements and related costs for the antidepressant drug Paxil have cost drug giant GlaxoSmithKline close to $1 billion, Bloomberg news reported Monday.

    Comment?

    Related Topix: Research Triangle Park, NC, Biotech

  15. Novel drug combo improves breast cancer survivalRead the original story w/Photo

    18 hrs ago | KEPR CBS 19

    ... of Duke University. She led the combo treatment study and has consulted for its sponsor, British-based GlaxoSmithKline PLC, which makes Tykerb, and for Genentech, which makes Herceptin and Avastin. Women in the study had already received Herceptin ...

    Comment?

    Related Topix: Medicine, Health, Breast Cancer, Texas

  16. New Bone Healthy Workout Helps Women with Osteoporosis or Bone Loss Build and Maintain Strong BonesRead the original story

    18 hrs ago | Chiropractic Economics

    ... any new physical activities. The Rally With Sally For Bone Health(SM) campaign , sponsored by Roche and GlaxoSmithKline, is a program that helps women understand and actively manage osteoporosis and bone loss. Media Contacts Mark O'Connor/Ogilvy ...

    Comment?

    Related Topix: Public Relations, Life, Food, Nutrition

  17. Allergy says positive results for ragweed vaccineRead the original story

    19 hrs ago | Chiropractic Economics

    ... products, Allergy said. The new adjuvant, which contains MPL used by a number of companies, including by GlaxoSmithKline in its Cervarix cervical cancer vaccine, has been approved in Europe but not in the Unites States. Analyst Robin Campbell at ...

    Comment?

    Related Topix: AGY Therapeutics, Startups, Gaming, Argosy Gaming, Medicine, Conjunctivitis, Health, Food and Drug Administration, Marketing

  18. One Million Boxes of Over-the-Counter Smoking Cessation Products Sold in January 2008

    19 hrs ago | Chiropractic Economics

    GlaxoSmithKline Consumer Healthcare today announced that it sold one million boxes of smoking cessation products in January 2008, which includes NicoDerm CQ patches, Nicorette gum, and Commit lozenges.

    Comment?

    Related Topix: Smoking, Medicine, Health, Habitrol, NicoDerm CQ, Nicotrol, Medication, Biotech, Nicorette, Nicotine Gum (generic), Nicotine, NicoDerm, Nicotine (generic)

  19. Bloomberg: GSK has paid $1B in Paxil suitsRead the original story

    20 hrs ago | Triangle Business Journal

    GlaxoSmithKline , the London-based pharmaceutical giant with U.S. headquarters in Research Triangle Park, has paid close to $1 billion since 1993 to resolve lawsuits surrounding its antidrepessant Paxil, according to a report from Bloomberg News.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Research Triangle Park, NC

  20. Paxil Suicide, Birth Defect Lawsuit Settlements DetailedRead the original story

    21 hrs ago | Personal Injury Law News

    Paxil maker GlaxoSmithKline has paid over $1 billion to settle lawsuits involving the antidepressant since it came on the market in 1993, according to report on Bloomberg.com. Many of the Paxil settlements involved allegations that the drug led to suicides, attempted suicides or birth defects.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry